How much funding has Emulate raised?

Emulate has raised $203.0M in total funding, most recently a Series E round.

Who are Emulate's investors?

Emulate's investors include Northpond Ventures, Founders Fund, Alumni Ventures, Perceptive Advisors, Atel Ventures, NanoDimension.

Where is Emulate headquartered?

Emulate is headquartered in Boston, Massachusetts, United States.

What industry is Emulate in?

Emulate operates in Biotech, Healthcare.

Emulate

Human biology on a chip.

Boston, United States · Founded 2013 · $203.0M raised

Biotech

Healthcare

Headquarters: Boston, Massachusetts
Employees: 51–200
Founded: 2013
Business Model: B2B

Website: emulatebio.com
Total Funding: $203.0M
Last Round: $82.0M Series ESep 2021
Rounds: 6

About

Emulate, Inc. is the pioneer of Organ-on-a-Chip technology, spun out of Harvard's Wyss Institute in 2013. The company commercializes its Human Emulation System — microfluidic chips lined with living human cells that replicate organ-level biology — enabling pharmaceutical and biotech researchers to model disease and test drug candidates.

Summary

Emulate is a Biotech company based in Boston, United States, founded in 2013. It has raised $203.0M in total across 6 rounds, most recently a $82.0M Series E round in Sep 2021. Investors include Northpond Ventures, Founders Fund and Alumni Ventures.

LinkedIn X (Twitter)